Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2025-06-09 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
2024年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as "2024 年年度股东大会会议资料" which translates to "2024 Annual General Meeting (AGM) Materials." It contains detailed agenda items for the 2024 AGM, including reports from the board, supervisory committee, independent directors, annual report and summary, financial statements, profit distribution plan, related party transactions, remuneration proposals, and insurance for directors and officers. The document includes meeting instructions, voting procedures, and detailed reports to be presented at the AGM. The length is substantial (15,000 characters), and the content is clearly the materials prepared for the AGM rather than a brief announcement or a transcript of the meeting. Therefore, this document fits the category of AGM Information (AGM-R).
2025-06-09 Chinese
关于召开2024年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice from the board of directors of Shanghai MicroPort EP MedTech Co., Ltd. regarding the convening of the 2024 Annual General Meeting (AGM) scheduled for June 18, 2025. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed and voted on, instructions for shareholders on attendance and proxy voting, and other procedural details. The document does not contain financial statements or results but is focused on informing shareholders about the AGM logistics and agenda. The document length is 3545 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or notices about it.
2025-05-27 Chinese
关于召开2024年度暨2025年第一季度业绩暨现金分红说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement by Shanghai MicroPort EP MedTech Co., Ltd. about holding an investor meeting to discuss the 2024 annual and 2025 first quarter financial results and cash dividend. It specifies the date, time, location, and format of the meeting, and invites investors to participate and ask questions. The document references that the 2024 annual report and 2025 first quarter report have already been disclosed on March 28 and April 30, respectively. The document itself does not contain financial statements or detailed financial data but is an announcement of an upcoming investor presentation event focused on financial results and dividends. Therefore, it fits best as an Investor Presentation (IP) announcement rather than the actual reports or earnings releases.
2025-05-23 Chinese
2025年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 First Quarter Report" of Shanghai MicroPort EP MedTech Co., Ltd. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on non-recurring gains and losses. The report covers the first quarter of 2025 and includes unaudited financial statements. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is over 13,000 characters, indicating it is the full report, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2025
2025-04-29 Chinese
舆情管理制度
Governance Information Classification · 95% confidence The document is titled '舆情管理制度' which translates to 'Public Opinion Management System' or 'Crisis Management Policy'. It outlines the company's internal policies and procedures for managing public opinion, media reports, and potential crises that could affect the company's reputation and stock price. It includes organizational structure, responsibilities, response principles, reporting procedures, and confidentiality obligations. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no management changes, no capital updates, no earnings information, or any other typical financial or regulatory report content. The document is a governance-related internal policy document rather than a report or announcement. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 3382 characters, which is relatively short but contains substantive policy content, not just an announcement or certification. Hence, it is not RPA or RNS.
2025-04-29 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司2024年度持续督导跟踪报告
Regulatory Filings Classification · 95% confidence The document is titled as a "2024年度持续督导跟踪报告" (2024 Annual Continuous Supervision Tracking Report) issued by the sponsor 华泰联合证券有限责任公司 for 上海微创电生理医疗科技股份有限公司. It discusses the use of raised funds, compliance with regulations, financial data for 2024, risk factors, R&D progress, and other supervisory matters related to the company's IPO and ongoing compliance. The document is detailed, contains substantive financial data, and is a continuous supervision report rather than a full annual report or earnings release. It is not a simple announcement or certification but a comprehensive supervisory report required by securities regulations for companies post-IPO. This type of document fits best under the category of Regulatory Filings (RNS) as it is a regulatory compliance report that does not fit the other specific categories like Annual Report (10-K) or Interim Report (IR).
2025-04-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.